Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 274

1.

Analysis of Long-term Outcomes of Radiotherapy and Verteporfin Photodynamic Therapy for Circumscribed Choroidal Hemangioma.

Papastefanou VP, Plowman PN, Reich E, Pavlidou E, Restori M, Hungerford JL, Arora AK, Cohen VML, Sagoo MS.

Ophthalmol Retina. 2018 Aug;2(8):842-857. doi: 10.1016/j.oret.2017.12.002. Epub 2018 Jan 12.

PMID:
31047538
2.

A Phase I Study of Pegylated Arginine Deiminase (Pegargiminase), Cisplatin, and Pemetrexed in Argininosuccinate Synthetase 1-Deficient Recurrent High-grade Glioma.

Hall PE, Lewis R, Syed N, Shaffer R, Evanson J, Ellis S, Williams M, Feng X, Johnston A, Thomson JA, Harris FP, Jena R, Matys T, Jefferies S, Smith K, Wu BW, Bomalaski JS, Crook T, O'Neill K, Paraskevopoulos D, Khadeir RS, Sheaff M, Pacey S, Plowman PN, Szlosarek PW.

Clin Cancer Res. 2019 May 1;25(9):2708-2716. doi: 10.1158/1078-0432.CCR-18-3729. Epub 2019 Feb 22.

PMID:
30796035
3.
4.

The PARP-1 inhibitor Olaparib suppresses BRCA1 protein levels, increases apoptosis and causes radiation hypersensitivity in BRCA1+/- lymphoblastoid cells.

Bourton EC, Ahorner PA, Plowman PN, Zahir SA, Al-Ali H, Parris CN.

J Cancer. 2017 Oct 23;8(19):4048-4056. doi: 10.7150/jca.21338. eCollection 2017.

5.

An unusual adrenal cause of hypoglycaemia.

O'Toole SM, Turner BC, Plowman PN, Batterham RL, Drake WM.

QJM. 2017 Oct 1;110(10):675-676. doi: 10.1093/qjmed/hcx128. No abstract available.

PMID:
28666340
6.

Using circulating cell-free DNA to monitor personalized cancer therapy.

Oellerich M, Schütz E, Beck J, Kanzow P, Plowman PN, Weiss GJ, Walson PD.

Crit Rev Clin Lab Sci. 2017 May;54(3):205-218. doi: 10.1080/10408363.2017.1299683. Epub 2017 Apr 10. Review.

PMID:
28393575
7.

Stereotactic radiosurgery XX: ocular neuromyotonia in association with gamma knife radiosurgery.

Sze WC, McQuillan J, Plowman PN, MacDougall N, Blackburn P, Sabin HI, Ali N, Drake WM.

Endocrinol Diabetes Metab Case Rep. 2015;2015:140106. doi: 10.1530/EDM-14-0106. Epub 2015 Aug 4.

8.

Increased γ-H2AX and Rad51 DNA Repair Biomarker Expression in Human Cell Lines Resistant to the Chemotherapeutic Agents Nitrogen Mustard and Cisplatin.

Adam-Zahir S, Plowman PN, Bourton EC, Sharif F, Parris CN.

Chemotherapy. 2014;60(5-6):310-20. doi: 10.1159/000430086. Epub 2015 Jul 1.

PMID:
26138778
9.

Enhanced γ-H2AX DNA damage foci detection using multimagnification and extended depth of field in imaging flow cytometry.

Parris CN, Adam Zahir S, Al-Ali H, Bourton EC, Plowman C, Plowman PN.

Cytometry A. 2015 Aug;87(8):717-23. doi: 10.1002/cyto.a.22697. Epub 2015 Jun 18.

10.

Outcomes of primary lymphoma of the ocular adnexa (orbital lymphoma) treated with radiotherapy.

Woolf DK, Kuhan H, Shoffren O, Akinnawo EM, Sivagurunathan B, Boyce H, Plowman PN.

Clin Oncol (R Coll Radiol). 2015 Mar;27(3):153-9. doi: 10.1016/j.clon.2014.10.002. Epub 2014 Oct 29.

PMID:
25455843
11.

Primary intraocular lymphoma.

Sagoo MS, Mehta H, Swampillai AJ, Cohen VM, Amin SZ, Plowman PN, Lightman S.

Surv Ophthalmol. 2014 Sep-Oct;59(5):503-16. doi: 10.1016/j.survophthal.2013.12.001. Epub 2013 Dec 31. Review.

12.

Sequelae and survivorship in patients treated with (131)I-MIBG therapy.

Sze WC, Grossman AB, Goddard I, Amendra D, Shieh SC, Plowman PN, Drake WM, Akker SA, Druce MR.

Br J Cancer. 2013 Aug 6;109(3):565-72. doi: 10.1038/bjc.2013.365. Epub 2013 Jul 16.

13.

Elevated expression of artemis in human fibroblast cells is associated with cellular radiosensitivity and increased apoptosis.

Ulus-Senguloglu G, Arlett CF, Plowman PN, Parnell J, Patel N, Bourton EC, Parris CN.

Br J Cancer. 2012 Oct 23;107(9):1506-13. doi: 10.1038/bjc.2012.443.

14.

Three cytotoxic drugs combined with pelvic radiation and as maintenance chemotherapy for patients with squamous cell carcinoma of the anus (SCCA): long-term follow-up of a phase II pilot study using 5-fluorouracil, mitomycin C and cisplatin.

Sebag-Montefiore D, Meadows HM, Cunningham D, Plowman PN, Hurman DC, Davidson N, Grieve R, Levine E, Glynne-Jones R.

Radiother Oncol. 2012 Aug;104(2):155-60. doi: 10.1016/j.radonc.2012.06.006. Epub 2012 Aug 1.

PMID:
22857859
15.

Primary lymphoma of the ocular adnexa (orbital lymphoma) and primary intraocular lymphoma.

Woolf DK, Ahmed M, Plowman PN.

Clin Oncol (R Coll Radiol). 2012 Jun;24(5):339-44. doi: 10.1016/j.clon.2012.03.001. Epub 2012 Apr 20. Review.

PMID:
22521959
16.

Multispectral imaging flow cytometry reveals distinct frequencies of γ-H2AX foci induction in DNA double strand break repair defective human cell lines.

Bourton EC, Plowman PN, Zahir SA, Senguloglu GU, Serrai H, Bottley G, Parris CN.

Cytometry A. 2012 Feb;81(2):130-7. doi: 10.1002/cyto.a.21171. Epub 2011 Dec 13.

17.

(Stereotactic) radiosurgery XIX: spinal radiosurgery--two year experience in a UK centre.

Martin AG, Cowley IR, Taylor BA, Cassoni AM, Landau DB, Plowman PN.

Br J Neurosurg. 2012 Feb;26(1):53-8. doi: 10.3109/02688697.2011.603857. Epub 2011 Oct 25.

PMID:
22026444
18.

Bevacizumab treatment for vestibular schwannomas in neurofibromatosis type two: report of two cases, including responses after prior gamma knife and vascular endothelial growth factor inhibition therapy.

Eminowicz GK, Raman R, Conibear J, Plowman PN.

J Laryngol Otol. 2012 Jan;126(1):79-82. doi: 10.1017/S0022215111002805. Epub 2011 Oct 18.

PMID:
22004800
19.

Prolonged expression of the γ-H2AX DNA repair biomarker correlates with excess acute and chronic toxicity from radiotherapy treatment.

Bourton EC, Plowman PN, Smith D, Arlett CF, Parris CN.

Int J Cancer. 2011 Dec 15;129(12):2928-34. doi: 10.1002/ijc.25953. Epub 2011 Apr 13.

20.

CyberKnife radiosurgery for an intracardiac metastasis.

Martin AG, Coltart DJ, Plowman PN.

BMJ Case Rep. 2011 Mar 3;2011. pii: bcr0720103197. doi: 10.1136/bcr.07.2010.3197. No abstract available.

21.

First quinquennial review of intensity-modulated radiotherapy at St Bartholomew's Hospital, London.

Smith D, MacDougall N, Monk J, Sibtain A, Powell ME, Plowman PN.

Clin Oncol (R Coll Radiol). 2010 Oct;22(8):666-74. doi: 10.1016/j.clon.2010.06.018. Epub 2010 Jul 31.

PMID:
20674299
22.
23.

No clear evidence for an association between GH replacement and relapse of intracranial germ cell tumours: single centre and KIMS experience.

Chung TT, Drake WM, Plowman PN, Metcalfe K, Grossman AB, Akker SA, Chew SL, Besser GM, Walker DM, Koltowska-Haggstrom M, Wilton P, Mattsson AF, Monson JP.

Eur J Endocrinol. 2010 Aug;163(2):357-8. doi: 10.1530/EJE-10-0498. Epub 2010 Jun 1. No abstract available.

PMID:
20516207
24.

Single photon emission computed tomography (SPECT)/computed tomography using Iodine-123 in patients with differentiated thyroid cancer: additional value over whole body planar imaging and SPECT.

Barwick T, Murray I, Megadmi H, Drake WM, Plowman PN, Akker SA, Chew SL, Grossman AB, Avril N.

Eur J Endocrinol. 2010 Jun;162(6):1131-9. doi: 10.1530/EJE-09-1023. Epub 2010 Mar 8.

PMID:
20212015
25.

The developing role for intensity-modulated radiation therapy (IMRT) in the non-surgical treatment of brain metastases.

Edwards AA, Keggin E, Plowman PN.

Br J Radiol. 2010 Feb;83(986):133-6. doi: 10.1259/bjr/28596848. Epub 2009 Dec 17.

26.

Diagnosis, management and therapeutic outcome in prepubertal Cushing's disease.

Dias RP, Kumaran A, Chan LF, Martin L, Afshar F, Matson M, Plowman PN, Monson JP, Besser GM, Grossman AB, Savage MO, Storr HL.

Eur J Endocrinol. 2010 Mar;162(3):603-9. doi: 10.1530/EJE-09-0509. Epub 2009 Dec 1.

PMID:
19952125
27.

A novel splice variant of the DNA-PKcs gene is associated with clinical and cellular radiosensitivity in a patient with xeroderma pigmentosum.

Abbaszadeh F, Clingen PH, Arlett CF, Plowman PN, Bourton EC, Themis M, Makarov EM, Newbold RF, Green MH, Parris CN.

J Med Genet. 2010 Mar;47(3):176-81. doi: 10.1136/jmg.2009.068866. Epub 2009 Sep 24.

28.

Gamma knife radiosurgery: a safe and effective salvage treatment for pituitary tumours not controlled despite conventional radiotherapy.

Swords FM, Monson JP, Besser GM, Chew SL, Drake WM, Grossman AB, Plowman PN.

Eur J Endocrinol. 2009 Dec;161(6):819-28. doi: 10.1530/EJE-09-0493. Epub 2009 Sep 22.

PMID:
19773368
29.

Positron emission tomography in the diagnosis and management of intracranial germ cell tumours.

Kelly PA, Metcalfe K, Evanson J, Sabin I, Plowman PN, Monson JP.

Horm Res. 2009;72(3):190-6. doi: 10.1159/000232496. Epub 2009 Sep 1.

PMID:
19729952
30.

A cross-over response to sequential use of sunitinib after sorafenib in a patient with metastatic renal cell carcinoma.

Richards TM, Plowman PN, Reznek R, Ball SA.

Clin Oncol (R Coll Radiol). 2009 Oct;21(8):633-4. doi: 10.1016/j.clon.2009.03.001. Epub 2009 Apr 19. No abstract available.

PMID:
19380217
31.

Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation.

Chan MP, Hungerford JL, Kingston JE, Plowman PN.

Br J Ophthalmol. 2009 Jul;93(7):891-4. doi: 10.1136/bjo.2007.129981. Epub 2009 Mar 26.

PMID:
19329423
32.

Early experience of tomotherapy-based intensity-modulated radiotherapy for breast cancer treatment.

O'Donnell H, Cooke K, Walsh N, Plowman PN.

Clin Oncol (R Coll Radiol). 2009 May;21(4):294-301. doi: 10.1016/j.clon.2009.01.010. Epub 2009 Feb 26.

PMID:
19249194
33.

The use of radiotherapy for the treatment of localized orbital amyloidosis.

Khaira M, Mutamba A, Meligonis G, Rose GE, Plowman PN, O'Donnell H.

Orbit. 2008;27(6):432-7. doi: 10.1080/01676830802350216.

PMID:
19085298
34.

Treatment of Nelson's syndrome with temozolomide.

Moyes VJ, Alusi G, Sabin HI, Evanson J, Berney DM, Kovacs K, Monson JP, Plowman PN, Drake WM.

Eur J Endocrinol. 2009 Jan;160(1):115-9. doi: 10.1530/EJE-08-0557. Epub 2008 Nov 4.

PMID:
18984772
35.

Indications for tomotherapy/intensity-modulated radiation therapy in paediatric radiotherapy: extracranial disease.

Plowman PN, Cooke K, Walsh N.

Br J Radiol. 2008 Nov;81(971):872-80. doi: 10.1259/bjr/14878999.

PMID:
18941047
36.

Recent London improvements in curative radiation therapy for relevant early prostate cancer.

Plowman PN.

Ann N Y Acad Sci. 2008 Sep;1138:257-66. doi: 10.1196/annals.1414.031.

PMID:
18837905
37.

Advances in the management of paediatric Cushing's disease.

Savage MO, Chan LF, Afshar F, Plowman PN, Grossman AB, Storr HL.

Horm Res. 2008;69(6):327-33. doi: 10.1159/000117388. Epub 2008 Mar 17.

38.

Focal radiation therapy for patients with persistent/recurrent pituitary adenoma, despite previous radiotherapy.

Edwards AA, Swords FM, Plowman PN.

Pituitary. 2009;12(1):30-4. doi: 10.1007/s11102-008-0115-5. Review.

PMID:
18437578
39.

A dosimetric comparison between two intensity-modulated radiotherapy techniques: tomotherapy vs dynamic linear accelerator.

Whitelaw GL, Blasiak-Wal I, Cooke K, Usher C, Macdougall ND, Plowman PN.

Br J Radiol. 2008 Apr;81(964):333-40. doi: 10.1259/bjr/67084583.

PMID:
18344277
40.

Re-defining rectal volume and DVH for analysis of rectal morbidity risk after radiotherapy for early prostate cancer.

O'Donnell HE, Finnegan K, Eliades H, Oliveros S, Plowman PN.

Br J Radiol. 2008 Apr;81(964):327-32. doi: 10.1259/bjr/75868623.

PMID:
18344276
41.

Minimal ionizing radiation sensitivity in a large cohort of xeroderma pigmentosum fibroblasts.

Arlett CF, Green MH, Rogers PB, Lehmann AR, Plowman PN.

Br J Radiol. 2008 Jan;81(961):51-8.

PMID:
18079351
42.

PET scanning and Gamma Knife radiosurgery in the early diagnosis and salvage "cure" of locally recurrent nasopharyngeal carcinoma.

O'Donnell HE, Plowman PN, Khaira MK, Alusi G.

Br J Radiol. 2008 Jan;81(961):e26-30.

PMID:
18079348
43.

Eyelid tumours.

Plowman PN.

Orbit. 2007 Sep;26(3):207-13. Review. No abstract available.

PMID:
17891649
44.

Long-term anterior pituitary function in patients with paediatric Cushing's disease treated with pituitary radiotherapy.

Chan LF, Storr HL, Plowman PN, Perry LA, Besser GM, Grossman AB, Savage MO.

Eur J Endocrinol. 2007 Apr;156(4):477-82.

PMID:
17389463
45.

IMRT in abdominal neuroblastoma.

Plowman PN, Cooke K, Blasiak-Wal I, Walsh N.

Pediatr Blood Cancer. 2007 Jun 15;48(7):714; author reply 715. No abstract available.

PMID:
17091484
46.

Cross-over response to erlotinib of brain metastatic disease from bronchial adenocarcinoma after gefitinib failure, and an unusual rash.

Walther JC, Khorshid M, Gaya A, Plowman PN.

Clin Oncol (R Coll Radiol). 2006 Oct;18(8):637-9. No abstract available.

PMID:
17051957
47.

Clinical and cellular ionizing radiation sensitivity in a patient with xeroderma pigmentosum.

Arlett CF, Plowman PN, Rogers PB, Parris CN, Abbaszadeh F, Green MH, McMillan TJ, Bush C, Foray N, Lehmann AR.

Br J Radiol. 2006 Jun;79(942):510-7.

PMID:
16714754
48.

Chemotherapy and radiotherapy causing radiation myelopathy: what is to blame?

Walther J, Sivabalasingham S, Plowman PN.

Clin Oncol (R Coll Radiol). 2006 Feb;18(1):86. No abstract available.

PMID:
16477928
49.

The management of differentiated thyroid cancer using 123I for imaging to assess the need for 131I therapy.

Ali N, Sebastian C, Foley RR, Murray I, Canizales AL, Jenkins PJ, Drake WM, Plowman PN, Besser GM, Chew SL, Grossman AB, Monson JP, Britton KE.

Nucl Med Commun. 2006 Feb;27(2):165-9.

PMID:
16404230
50.

Comparison of radiosurgery planning modalities for acoustic neuroma with regard to conformity and mean target dose.

Perks JR, El-Hamri K, Blackburn TP, Plowman PN.

Stereotact Funct Neurosurg. 2005;83(4):165-71. Epub 2005 Nov 25.

PMID:
16319520

Supplemental Content

Loading ...
Support Center